D

Diagnosticos da America SA
BOVESPA:DASA3

Watchlist Manager
Diagnosticos da America SA
BOVESPA:DASA3
Watchlist
Price: 2.34 BRL -3.31% Market Closed
Market Cap: 1.7B BRL
Have any thoughts about
Diagnosticos da America SA?
Write Note

Intrinsic Value

The intrinsic value of one DASA3 stock under the Base Case scenario is 14.82 BRL. Compared to the current market price of 2.34 BRL, Diagnosticos da America SA is Undervalued by 84%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DASA3 Intrinsic Value
14.82 BRL
Undervaluation 84%
Intrinsic Value
Price
D
Base Case Scenario

Valuation Backtest
Diagnosticos da America SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DASA3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DASA3?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Diagnosticos da America SA

Provide an overview of the primary business activities
of Diagnosticos da America SA.

What unique competitive advantages
does Diagnosticos da America SA hold over its rivals?

What risks and challenges
does Diagnosticos da America SA face in the near future?

Summarize the latest earnings call
of Diagnosticos da America SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Diagnosticos da America SA.

Provide P/S
for Diagnosticos da America SA.

Provide P/E
for Diagnosticos da America SA.

Provide P/OCF
for Diagnosticos da America SA.

Provide P/FCFE
for Diagnosticos da America SA.

Provide P/B
for Diagnosticos da America SA.

Provide EV/S
for Diagnosticos da America SA.

Provide EV/GP
for Diagnosticos da America SA.

Provide EV/EBITDA
for Diagnosticos da America SA.

Provide EV/EBIT
for Diagnosticos da America SA.

Provide EV/OCF
for Diagnosticos da America SA.

Provide EV/FCFF
for Diagnosticos da America SA.

Provide EV/IC
for Diagnosticos da America SA.

Show me price targets
for Diagnosticos da America SA made by professional analysts.

What are the Revenue projections
for Diagnosticos da America SA?

How accurate were the past Revenue estimates
for Diagnosticos da America SA?

What are the Net Income projections
for Diagnosticos da America SA?

How accurate were the past Net Income estimates
for Diagnosticos da America SA?

What are the EPS projections
for Diagnosticos da America SA?

How accurate were the past EPS estimates
for Diagnosticos da America SA?

What are the EBIT projections
for Diagnosticos da America SA?

How accurate were the past EBIT estimates
for Diagnosticos da America SA?

Compare the revenue forecasts
for Diagnosticos da America SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Diagnosticos da America SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Diagnosticos da America SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Diagnosticos da America SA compared to its peers.

Compare the P/E ratios
of Diagnosticos da America SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Diagnosticos da America SA with its peers.

Analyze the financial leverage
of Diagnosticos da America SA compared to its main competitors.

Show all profitability ratios
for Diagnosticos da America SA.

Provide ROE
for Diagnosticos da America SA.

Provide ROA
for Diagnosticos da America SA.

Provide ROIC
for Diagnosticos da America SA.

Provide ROCE
for Diagnosticos da America SA.

Provide Gross Margin
for Diagnosticos da America SA.

Provide Operating Margin
for Diagnosticos da America SA.

Provide Net Margin
for Diagnosticos da America SA.

Provide FCF Margin
for Diagnosticos da America SA.

Show all solvency ratios
for Diagnosticos da America SA.

Provide D/E Ratio
for Diagnosticos da America SA.

Provide D/A Ratio
for Diagnosticos da America SA.

Provide Interest Coverage Ratio
for Diagnosticos da America SA.

Provide Altman Z-Score Ratio
for Diagnosticos da America SA.

Provide Quick Ratio
for Diagnosticos da America SA.

Provide Current Ratio
for Diagnosticos da America SA.

Provide Cash Ratio
for Diagnosticos da America SA.

What is the historical Revenue growth
over the last 5 years for Diagnosticos da America SA?

What is the historical Net Income growth
over the last 5 years for Diagnosticos da America SA?

What is the current Free Cash Flow
of Diagnosticos da America SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Diagnosticos da America SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Diagnosticos da America SA

Current Assets 9.2B
Cash & Short-Term Investments 3B
Receivables 5.4B
Other Current Assets 827.4m
Non-Current Assets 18.9B
Long-Term Investments 11m
PP&E 6.3B
Intangibles 10.5B
Other Non-Current Assets 2.1B
Current Liabilities 5.6B
Accounts Payable 1.3B
Accrued Liabilities 1.2B
Other Current Liabilities 3.1B
Non-Current Liabilities 15.3B
Long-Term Debt 12.1B
Other Non-Current Liabilities 3.3B
Efficiency

Earnings Waterfall
Diagnosticos da America SA

Revenue
14.8B BRL
Cost of Revenue
-10.8B BRL
Gross Profit
4B BRL
Operating Expenses
-2.9B BRL
Operating Income
1B BRL
Other Expenses
-2B BRL
Net Income
-998.4m BRL

Free Cash Flow Analysis
Diagnosticos da America SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company reported a 9% increase in gross revenue to over BRL 2 billion, driven by a 4% rise in patient volume and better segment mix. Efficiency improvements, such as closing low-revenue units and digitalization, led to a 14% increase in adjusted gross profit and a 1.7 percentage point gain in adjusted gross margin. EBITDA grew 27%, with a 2.4 percentage point margin expansion. A capital infusion of BRL 1.5 billion significantly reduced net debt. The company's operational excellence program continues, aiming for sustainable, long-term growth.

What is Earnings Call?
Fundamental Scores

DASA3 Profitability Score
Profitability Due Diligence

Diagnosticos da America SA's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
ROIC is Increasing
41/100
Profitability
Score

Diagnosticos da America SA's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

DASA3 Solvency Score
Solvency Due Diligence

Diagnosticos da America SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
28/100
Solvency
Score

Diagnosticos da America SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DASA3 Price Targets Summary
Diagnosticos da America SA

Wall Street analysts forecast DASA3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DASA3 is 7.69 BRL with a low forecast of 2.93 BRL and a high forecast of 21.84 BRL.

Lowest
Price Target
2.93 BRL
25% Upside
Average
Price Target
7.69 BRL
229% Upside
Highest
Price Target
21.84 BRL
833% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DASA3?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DASA3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Diagnosticos da America SA

Country

Brazil

Industry

Health Care

Market Cap

1.7B BRL

Dividend Yield

0%

Description

Diagnósticos da América SA engages in medical diagnostics services and in the business of research and development of diagnostic tests and their application to the medical practice. The company is headquartered in Barueri, Sao Paulo. The company went IPO on 2004-11-19. The Company’s services are structured into three units: Ambulatory and Hospital, which provides clinical analyses and diagnostic imaging; Laboratory support, which provides services for small and medium-sized laboratories, and Public Health Sector, in which the Company operates through the CientificaLab brand, which focuses on providing auxiliary diagnostic support services for the public health sector. In addition, the Company is engaged in activities related to tests in food and substances to evaluate risks for the human being; import, for its own use, of medical-hospital equipment, sets for diagnostics and related material in general, and granting and administration of business franchising, including advertising and publishing fund, training and selection of labor, supplying of equipment and research material suppliers, among others.

Contact

SAO PAULO
Barueri
Avenida Jurua, 434
+551126303000
www.dasa3.com.br

IPO

2004-11-19

Employees

-

Officers

Chief Executive Officer
Mr. Licio Tavares Angelo Cintra
Chief Financial Officer
Mr. Andre Covre
Chief Radiology & Imaging Diagnosis Officer and Member of Management Board
Mr. Emerson Leandro Gasparetto
General Director & Chief Investor Relations Officer
Mr. Carlos de Barros Jorge Neto Neto
Chief Legal & Compliance Officer
Mr. Fábio Ferreira Cunha
Vice-President of Human Resources
Mr. Adriano Brito da Costa Lima
Show More
Investor Relations Officer
Mr. Glauco Desiderio
Show Less

See Also

Discover More
What is the Intrinsic Value of one DASA3 stock?

The intrinsic value of one DASA3 stock under the Base Case scenario is 14.82 BRL.

Is DASA3 stock undervalued or overvalued?

Compared to the current market price of 2.34 BRL, Diagnosticos da America SA is Undervalued by 84%.

Back to Top